Position in TWST
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,952,250
+$921,684 QoQ
Shares Held
18,976
-12.5% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#151
of 337 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TWST Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $43,640,056 across 72 Biotechnology names. TWST ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
58,590 | $7,776,650 | |
| 2 | TECH |
BIO-TECHNE Corp
|
91,696 | $6,478,322 | |
| 3 | PGEN |
Precigen, Inc.
|
882,267 | $5,028,921 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
113,104 | $4,002,750 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10,997 | $2,059,518 | |
| 6 | TWST |
Twist Bioscience Corp
This page
|
18,976 | $1,952,250 | |
| 7 | QURE |
uniQure N.V.
|
32,229 | $1,484,467 | |
| 8 | MDXG |
Mimedx Group, Inc.
|
215,239 | $828,670 |
All Filings in TWST
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,952,250 | 18,976 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,030,566 | 21,687 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $698,950 | 22,035 | Shares | Other | 2026-02-17 | |
| 2021-12-31 | $214,602 | 2,773 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $331,607 | 3,100 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $659,430 | 5,324 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $992,986 | 7,028 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $783,554 | 10,314 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $1,036,464 | 22,880 | Shares | Other | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||